|
| related topics |
| {product, liability, claim} |
| {control, financial, internal} |
| {stock, price, share} |
| {provision, law, control} |
| {personnel, key, retain} |
| {property, intellectual, protect} |
| {capital, credit, financial} |
| {cost, regulation, environmental} |
| {financial, litigation, operation} |
| {competitive, industry, competition} |
| {product, market, service} |
|
|
The FDA Denied the Company s Claims in its 510(k) Pre-Market Notification and the Company s Appeal May Not Be Successful
The Company Has Limited Sources of Working Capital
The Company Has a History of Losses
The Company Has a Short Operating History and Limited Operating Experience
The Company s Intellectual Property Assets Are Critical to Its Success
The AutoloGel Components are Subject to Governmental Regulation
The Company Could Be Adversely Affected if Customers Cannot Obtain Reimbursement
The Success of the AutoloGel System Is Dependent on Acceptance by the Medical Community
The Company May Be Unable to Attract and Retain Key Personnel
Legislative and Administrative Action May Have an Adverse Effect on the Company
The Company Could Be Affected by Malpractice Claims
Has Existing Competition in the Marketplace
Risks Related to the Company s Common Stock
The Company is Subject to Anti-Takeover Provisions and Laws.
Purchases of the Company s Common Stock Are Subject to the SEC's Penny Stock Rules.
Full 10-K form ▸
|
|
| related documents |
| 918112--8/31/2009--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/ |
| 1030206--2/2/2010--VASCULAR_SOLUTIONS_INC |
| 918112--9/28/2010--NEUROBIOLOGICAL_TECHNOLOGIES_INC_/CA/ |
| 1050007--11/29/2007--NUTRACEUTICAL_INTERNATIONAL_CORP |
| 1030206--2/5/2008--VASCULAR_SOLUTIONS_INC |
| 1030206--2/3/2009--VASCULAR_SOLUTIONS_INC |
| 882873--9/20/2007--UROLOGIX_INC |
| 59440--3/16/2007--VECTOR_GROUP_LTD |
| 882873--9/21/2009--UROLOGIX_INC |
| 816284--2/18/2010--CELGENE_CORP_/DE/ |
| 1050007--11/20/2008--NUTRACEUTICAL_INTERNATIONAL_CORP |
| 882873--9/17/2010--UROLOGIX_INC |
| 811669--2/23/2007--UST_INC |
| 10081--8/30/2006--BARR_PHARMACEUTICALS_INC |
| 874716--2/27/2008--IDEXX_LABORATORIES_INC_/DE |
| 1104280--12/3/2010--SANGUI_BIOTECH_INTERNATIONAL_INC |
| 1006195--6/8/2009--MATRIXX_INITIATIVES_INC |
| 882873--9/29/2008--UROLOGIX_INC |
| 1089143--9/13/2007--COLLECTORS_UNIVERSE_INC |
| 776008--3/14/2006--STAR_SCIENTIFIC_INC |
| 793279--9/13/2006--CANDELA_CORP_/DE/ |
| 1347022--2/12/2009--VeriChip_CORP |
| 793279--9/11/2008--CANDELA_CORP_/DE/ |
| 793279--9/13/2007--CANDELA_CORP_/DE/ |
| 1050007--11/23/2010--NUTRACEUTICAL_INTERNATIONAL_CORP |
| 874710--9/26/2008--ALLIED_HEALTHCARE_PRODUCTS_INC |
| 1372020--3/17/2008--Great_Lakes_Dredge_&_Dock_CORP |
| 862668--10/13/2009--ESCALON_MEDICAL_CORP |
| 879682--3/28/2006--PLC_SYSTEMS_INC |
| 810084--4/2/2007--BIOJECT_MEDICAL_TECHNOLOGIES_INC |
|